Discussion: The role of preprints in Asian science

On December 6, life sciences and medical researchers in Asia will discuss their views on preprints in science with eLife editors.
  • Views 64
person with glasses stares at a screen containing code

Preprints are the quickest opportunity for authors to share their findings with the rest of the research community. Yet, use of this format differs across disciplines and geographies of science and medicine. At this event, we’re looking to hear from Asian researchers about their experiences and views on this topic.

The COVID-19 pandemic has seen researchers, as well as policy-makers and the wider society, acknowledge and use preprints as a popular source of new knowledge. Can early-results sharing become mainstream practice in Asia? Do researchers see findings presented in preprints as robust and trustworthy?

Our participants will discuss opportunities and reservations to preprinting their own science with Kathryn Cheah, Professor in Molecular Genetics, University of Hong Kong and eLife Senior Editor, Jiwon Shim, Professor at Hanyang University, South Korea, and eLife Reviewing Editor, and Chee Wai Chua, PI at the Shanghai Jiao Tong University, China and an eLife Community Ambassador.

The session will involve:

  • Introduction by Chee Wai Chua
  • Role of preprints in the future of scientific communications by Kathryn Cheah and Jiwon Shim
  • Participant-led discussions about experiences with preprints in life sciences and medicine
  • Q&A about the "publish, then review" process at eLife

The event will take place December 6th, 2021, 8-9.30am London, UK | 2-3.30pm Beijing, China.

Registration closed on 10am London | 4pm Beijing on December 3.

Please note that English will be our working language at this event.


Questions and comments are welcome. Please annotate publicly on the article or contact us at hello [at] elifesciences [dot] org.

For the latest updates and other news from eLife, sign up to receive our bi-monthly newsletter. You can also follow @eLife on Twitter